Table 2.
Variable | Univariable | Multiple linear regression | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
R2 | B | 95% CI | p | Adj. R2 | B | 95% CI | p | |||
| ||||||||||
Lower | Upper | Lower | Upper | |||||||
Age in years | 0.080 | 0.08 | 0.01 | 0.14 | 0.029 | 0.134 | −0.01 | 0.08 | −0.10 | 0.796 |
Treatment group | ||||||||||
Natesto | Ref. | Ref. | ||||||||
TC | 0.200 | 3.15 | 1.50 | 4.81 | <0.001 | 3.24 | 0.74 | 5.73 | 0.012 | |
BMI (kg/m2) | 0.0002 | −0.01 | −0.17 | 0.15 | 0.921 | 0.04 | −0.12 | 0.19 | 0.644 | |
Smoking history | ||||||||||
No | Ref. | Ref. | ||||||||
Yes | 0.006 | 0.66 | −1.52 | 2.85 | 0.546 | 0.42 | −1.69 | 2.53 | 0.694 | |
Followup testosterone (10 ng/dL increase) | 0.050 | 0.02 | −0.003 | 0.05 | 0.085 | 0.004 | −0.02 | 0.03 | 0.730 |
B: unstandardized regression coefficient; BMI: body mass index; CI: confidence interval; R2: coefficient of determination; adj. R2: adjusted coefficient of determination; Ref.: reference value; TC: testosterone cypionate.